Skip to main content

Table 4 Topic raised according to type of treatment

From: Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors

TopicTreatment groupN (%)Crude OR (95% CI)P-valueAdjusted ORa (95% CI)P-value
PainSRT13/64 (20)1.0 (ref) 1.0 (ref) 
MMT33/96 (34)2.1 (0.94.3)0.062.1 (0.94.8)0.07
FatigueSRT13/64 (20)1.0 1.0 
MMT50/96 (52)4.3 (2.1–8.8)< 0.0014.3 (1.9–9.5)< 0.001
Bowel/urinationSRT1/64 (2)1.0 1.0 
MMT6/96 (6)4.2 (0.536)0.195.4 (0.554)0.15
SexualSRT6/64 (9)1.0 1.0 
MMT14/96 (15)1.7 (0.64.5)0.331.3 (0.43.9)0.68
MobilitySRT9/64 (14)1.0 1.0 
MMT27/96 (28)2.4 (1.0–5.5)0.042.4 (0.95.8)0.06
PsychologicalSRT6/64 (9)1.0 1.0 
MMT13/96 (14)1.5 (0.54.2)0.421.0 (0.33.2)0.96
OtherSRT11/64 (17)1.0 1.00.54
MMT12/96 (12)0.7 (0.31.7)0.4105 (0.32.0) 
PeerSRT3/64 (5)1.0 1.0 
MMT7/96 (7)1.6 (0.46.4)0.512.0 (0.49.8)0.36
No topicSRT11/64 (17)1.0 1.0 
MMT9/96 (8)0.5 (0.21.3)0.150.4 (0.11.3)0.14
  1. N are presented as number of patients that raised the topic within the treatment group with % in the brackets
  2. Italic values indicate significance of P-value (P < 0.05)
  3. OR odds ratio, CI confidence interval, ref reference, SRT surgery/radiotherapy group, MMT multimodal therapy group
  4. aAdjusted for age and gender